Mayo Clinic Researchers Develop Prediction Tool for Kidney Stones - Insights
Mayo Clinic researchers are tracking the familiar characteristics of kidney stone formers in an online prediction tool that could help sufferers anticipate if they'll experience future episodes.
CPT codes and LOINC update: August 2023 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of August.
CPT codes and LOINC update: March 2023 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of March.
Mayo Clinic Laboratory and pathology research roundup: November 1 - Insights
This week's research roundup features: Alliance A071401: phase II trial of focal adhesion kinase inhibition in meningiomas with somatic NF2 mutations
Mayo Clinic Laboratory and pathology research roundup: October 4 - Insights
This week's research roundup features: Tumor microenvironment CD14+ cells correlate with poor overall survival in patients with early-stage lung adenocarcinoma
Mayo Clinic Laboratory and pathology research roundup: September 13 - Insights
This week's research roundup features: A simple score to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction
Mayo Clinic Laboratory and pathology research roundup: October 25 - Insights
This week's research roundup features: Automated scoring of total inflammation in renal allograft biopsies
Mayo Clinic Laboratory and pathology research roundup: November 8 - Insights
This week's research roundup features: Evaluating the significance of pancreatobiliary fluorescence in situ hybridization polysomy on prognosis in de novo cholangiocarcinoma
Mayo Clinic Laboratory and Pathology Research Roundup: Jan. 28 - Insights
This week’s Research Roundup highlights the diagnostic accuracy of echocardiography and intraoperative surgical inspection of the unicuspid aortic valve.
Mayo Clinic Laboratory and pathology research roundup: October 18 - Insights
This week's research roundup features: How do I warm HPC(A) products to maximize cell viability in the setting of cold agglutinin disease?